From our first articles we predicted that medical cannabis will be covered by medical benefits in time. This will ensure the survival of the medical stream while ensuring patients have affordable access to their
medication. Medication that often replaces more costly, but covered by benefits plans, medications – medications that may have undesired side effects.
Other than CFAMM, there seemed little coverage or interest in this. Perhaps because for many investors a prospective view of this nature was too far out on the horizon. Since that initial coverage, we have seen Sunlife Financial announce they intend to provide some coverage soon (CLICK HERE). You may recall that our Editor in Chief, Louis Kyron, asked Great West Life when they would follow Sunlife’s lead and GWL replied and did so in an open Tweet – they would be at some point during 2018.
From our past content, you also know that any benefit plan with a Health Spending Account (HAS) has full coverage of medical cannabis under the HSA facility. You also know that Novus Acquisition and Development, Corp. (OTC Markets: NDEV), through its wholly owned subsidiary WCIG Insurance Services, Inc., was
recently on our cover and they announced on June 5th that they are “pleased to announce their roll out assessment of Novus Cannabis MedPlan in Canadian marketplace” (CLICK HERE).
NexgenRxTM Inc (NexgenRx) trades on the TSXV and has recently entered into a partnership with CannTrust Holdings Inc (TSX:TRST). For this news release CLICK HERE & CLICK AGAIN HERE.
NXG’s gross margin impresses:
249
NexgenRx Inc.
TSXV:NXG
As At June 11, 2018
Shares Outstanding: 67,619,216 (www.tmxmoney.com)
Share Price: $0.25 Market Cap: $16,904,804
CASE STUDY 2